Literature DB >> 377878

Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children.

M Mimouni, T Koivukangas, M Karp, Z Laron.   

Abstract

Two one-injection insulin regimens--a combination of intermediate-action NPH insulin with regular insulin and a combination of long-acting PZI insulin with regular insulin, all of porcine origin and manufactured by Nordisk Insulin Laboratories--were compared to a group of 10 juvenile diabetics, each child serving as his own control. The results of thrice daily urine tests were recorded for periods of 3 months during each regimen and the incidence of glucosuria of less than 1% constituted the index used for metabolic control. Although the total insulin dose was almost the same with both schemes, it was found that less glucose was excreted during the night and early morning with the PZI regimen than the NPH regimen, indicating that a single injection of NPH is insufficient for good diabetic control.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377878     DOI: 10.1007/bf02590764

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  5 in total

1.  The control of diabetes mellitus: is it achievable? Is it desirable?

Authors:  A Drash
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

2.  Combined use of regular and crystalline protamine (NPH) insulins in the treatment of severe diabetes.

Authors:  W Oakley; D Hill; N Oakley
Journal:  Diabetes       Date:  1966-03       Impact factor: 9.461

Review 3.  Insulin preparations and the clinical use of insulin.

Authors:  J E Poulsen; T Deckert
Journal:  Acta Med Scand Suppl       Date:  1976

4.  Effect of multiple daily insulin injections on the course of diabetic retinopathy.

Authors:  E Eschwege; C Guyot-Argenton; J P Aubry; G Tchobroutsky
Journal:  Diabetes       Date:  1976-05       Impact factor: 9.461

5.  Glycosylated haemoglobin concentrations and clinitest results in insulin-dependent diabetes.

Authors:  R Lanoe; J Soria; N Thibult; C Soria; E Eschwege; G Tchobroutsky
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.